This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) slid 7.93% to $11.03 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.54% to 26,225.14 and Dow Jones Industrial Average falling 1.07% to 49,526.17.
This was the stock's second consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 46.35% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock underperformed when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. (VNDA) fell 1.72% to $6.28, Fortress Biotech Inc. (FBIO) rose 4.78% to $2.41, and Viking Therapeutics Inc. (VKTX) fell 4.54% to $30.27.
Trading volume (166,661) remained 100,153 below its 50-day average volume of 266,814.
Data source: Dow Jones Market Data, FactSet. Data compiled May 15, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-15-26 1720ET

CRBP

SBIO

Corbus Pharmaceuticals Holdings Inc. (CRBP) shares fell 7.93% to $11.03 on Friday, marking its second consecutive day of losses. The stock is now 46.35% below its 52-week high of $20.56. In comparison, competitors had mixed results, with Vanda Pharmaceuticals down 1.72%, Fortress Biotech up 4.78%, and Viking Therapeutics down 4.54%. Overall, the NASDAQ Composite Index dropped 1.54%.

MarketWatch Automated

Corbus Pharma

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

Proshares Ultra Nasdaq Biotech

Direxion S&P Biotech Bear 3X

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Invesco Nasdaq Biotechnology ETF

Direxion S&P Biotech Bull 3X

VanEck Biotech ETF

iShares Biotechnology ETF

NASDAQ Composite Index

Dow Jones Industrial Average

Vanda Pharma

Fortress Biotech

Viking Therap

Factset Research

Fortress Biotech Pref Share FBIOP 9.375 15/12/22

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors